Eli Lilly’s neutralizing antibody bamlanivimab receives US FDA emergency use authorization for the treatment of recently diagnosed COVID-19... Nov 12
The collaboration will provide the customers with AI solutions that help them to improve the quality of care... Nov 12
All the participants must be 18-85 years old, not pregnant, in good general health, and have not been previously diagnosed with COVID-19 ... Nov 12
ICMR is providing continuous support to Serum Institute of India in conducting and funding the ongoing clinical trials of COVISHIELD across 15 centres in India ... Nov 12
-Advertisements-